Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3852 |  ADCT ADC Therapeutics SA Common Shares | 0.98 USD | -1.01% | -7.55% | -16.24% | -69.18% | 125.11 M USD | ||
| 3857 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.68 USD | 0.00% | +12.77% | +36.44% | -46.64% | 121.38 M USD | ||
| 3859 |  VANI Vivani Medical, Inc. - Common Stock | 1.37 USD | -0.72% | +0.74% | +5.38% | +10.48% | 123.58 M USD | ||
| 3864 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.87 USD | -1.14% | +10.13% | +6.10% | +40.32% | 121.27 M USD | ||
| 3869 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.70 USD | -0.27% | +9.79% | -0.27% | +22.52% | 125.89 M USD | ||
| 3872 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.65 USD | +20.44% | +20.44% | +30.95% | -10.81% | 119.60 M USD | ||
| 3873 |  GUTS Fractyl Health, Inc. - Common Stock | 0.75 USD | -3.85% | +8.70% | -5.06% | -25.00% | 119.38 M USD | ||
| 3875 |  GNLX Genelux Corporation - Common Stock | 2.63 USD | -3.31% | -1.50% | -11.15% | -30.24% | 119.00 M USD | ||
| 3879 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.80 USD | +1.12% | +4.65% | -2.70% | -78.57% | 120.58 M USD | ||
| 3889 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.92 USD | +1.03% | +4.24% | +13.63% | -31.19% | 115.41 M USD | ||
| 3892 |  SEER Seer, Inc. - Class A Common Stock | 2.06 USD | +1.48% | +0.98% | +4.04% | -0.96% | 114.07 M USD | ||
| 3896 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 0.89 USD | -6.32% | -2.20% | -47.95% | +27.14% | 113.26 M USD | ||
| 3920 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.83 USD | -1.19% | -2.35% | +3.75% | -17.82% | 105.83 M USD | ||
| 3956 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.91 USD | +1.39% | +2.46% | -13.39% | +27.63% | 97.05 M USD | ||
| 3959 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.12 USD | -0.72% | +1.73% | +9.87% | -59.73% | 98.08 M USD | ||
| 3961 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.43 USD | -2.78% | +14.16% | +17.00% | -36.07% | 94.66 M USD | ||
| 3971 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.20 USD | -0.45% | +11.68% | +35.80% | +64.18% | 94.28 M USD | ||
| 3975 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.15 USD | +0.98% | +6.19% | +30.38% | +49.28% | 93.75 M USD | ||
| 3978 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +4.26% | -68.99% | 93.19 M USD | ||
| 3980 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.54 USD | +1.32% | -1.28% | +0.65% | -73.54% | 92.90 M USD |
Haberler Biotechnology Stocks
Alto Neuroscience hissesi 35,42 dolarla rekor kırdı
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
 BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
 CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |